beta

APRI

Apricus Biosciences Inc.

Apri

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

10-31-2018 08-09-2018 05-03-2018 03-01-2018 11-02-2017 after market close 08-02-2017 after market close 05-11-2017 after market close
Actual EPS -0.12 -0.1 -0.14 -0.16 -0.3 -0.15 -0.44
Consensus EPS -0.1 -0.13 -0.15 -0.17 1.24
Estimated EPS -0.1 -0.13 -0.15 -0.17 1.24
Number of Estimates 1 1 1 1 1
EPS Surprise -$0.04 -$0.03 -$0.15 $0.02 -$1.68

Stats

Summary

Apricus Biosciences Inc is a pharmaceutical company. It focuses on the development of product candidates in the areas of urology and rheumatology. The company has two product candidates currently in development invluding Vitaros and RayVa.

Market Cap: 35.3 Million

Primary Exchange: NASDAQ Capital Market

Website: http://www.apricusbio.com

Shares Outstanding: 15.2 Million

Float: 2.69 Million

Dividend: 0.0 (0.0%)

Beta: 0.434411

Sector: Healthcare

Industry: Drug Manufacturers

Short Interest (Jan 12, 2018): 762 Thousand

Ethical Flags

Animal testing

Longest drawdown: 1571 trading days

From: 2013-05-21 To: 2018-12-14

Lowest Point:

Apricus Biosciences reports Q3 results

via: SeekingAlpha at 2018-10-31 16:52:20:000

Apricus Biosciences (NASDAQ: APRI ): Q3 GAAP EPS of -$0.12. More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Biosciences reports Q3 results

via: SeekingAlpha at 2018-10-31 16:52:20:000

Apricus Biosciences (NASDAQ: APRI ): Q3 GAAP EPS of -$0.12. More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Biosciences reports Q3 results

via: SeekingAlpha at 2018-10-31 16:52:20:000

Apricus Biosciences (NASDAQ: APRI ): Q3 GAAP EPS of -$0.12. More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Biosciences beats by $0.02

via: SeekingAlpha at 2018-08-09 16:41:01:000

Apricus Biosciences (NASDAQ: APRI ): Q2 EPS of -$0.10 beats by $0.02 . More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Biosciences beats by $0.02

via: SeekingAlpha at 2018-08-09 16:41:01:000

Apricus Biosciences (NASDAQ: APRI ): Q2 EPS of -$0.10 beats by $0.02 . More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Biosciences beats by $0.02

via: SeekingAlpha at 2018-08-09 16:41:01:000

Apricus Biosciences (NASDAQ: APRI ): Q2 EPS of -$0.10 beats by $0.02 . More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , Read more … read more...

Apricus Bio up 29% premarket on merger with Seelos Therapeutics

via: SeekingAlpha at 2018-07-30 08:46:58:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) is up 29% premarket on increased volume in response to its planned merger with privately held Seelos Therapeutics in an all-stock deal. Seelos shareholders will own ~86% of the new company while Apricus shareholders will own ~14%. … read more...

Apricus Bio up 29% premarket on merger with Seelos Therapeutics

via: SeekingAlpha at 2018-07-30 08:46:58:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) is up 29% premarket on increased volume in response to its planned merger with privately held Seelos Therapeutics in an all-stock deal. Seelos shareholders will own ~86% of the new company while Apricus shareholders will own ~14%. … read more...

Apricus Bio up 29% premarket on merger with Seelos Therapeutics

via: SeekingAlpha at 2018-07-30 08:46:58:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) is up 29% premarket on increased volume in response to its planned merger with privately held Seelos Therapeutics in an all-stock deal. Seelos shareholders will own ~86% of the new company while Apricus shareholders will own ~14%. … read more...

Apricus Bio has work to do before refiling U.S. marketing application for ED cream Vitaros; shares down 10% premarket

via: SeekingAlpha at 2018-04-16 08:11:23:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) slips 10% premarket on light volume on the heels of FDA feedback that it needs to develop a new less-concentrated formulation of erectile dysfunction (ED) cream Vitaros (alprostadil, DDAIP.HCL) and conduct two new Phase 3 studies wit… read more...

Apricus Bio has work to do before refiling U.S. marketing application for ED cream Vitaros; shares down 10% premarket

via: SeekingAlpha at 2018-04-16 08:11:23:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) slips 10% premarket on light volume on the heels of FDA feedback that it needs to develop a new less-concentrated formulation of erectile dysfunction (ED) cream Vitaros (alprostadil, DDAIP.HCL) and conduct two new Phase 3 studies wit… read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-06 07:14:53:000

Noteworthy events during the week of April 8 - 14 for healthcare investors. More news on: Avita Medical Ltd., Immunovaccine Inc., Intercept Pharmaceuticals, Healthcare stocks news, , Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-04-06 07:14:53:000

Noteworthy events during the week of April 8 - 14 for healthcare investors. More news on: Avita Medical Ltd., Immunovaccine Inc., Intercept Pharmaceuticals, Healthcare stocks news, , Read more … read more...

Understanding Binary Catalysts: A Brief Guide For Biotech Investors

via: SeekingAlpha at 2018-03-29 02:38:12:000

This article was co-authored by Stepan Lavrouk. Stepan is an investment analyst with Almington Capital. We have written extensively on Seeking Alpha about a range of biotech stocks. But we have also spent some time addressing the activity of biotech investing itself. In previous articles… read more...

Understanding Binary Catalysts: A Brief Guide For Biotech Investors

via: SeekingAlpha at 2018-03-29 02:38:12:000

This article was co-authored by Stepan Lavrouk. Stepan is an investment analyst with Almington Capital. We have written extensively on Seeking Alpha about a range of biotech stocks. But we have also spent some time addressing the activity of biotech investing itself. In previous articles… read more...

Apricus Biosciences -27% on offering of stock, warrants

via: SeekingAlpha at 2018-03-27 18:51:07:000

Apricus Biosciences (NASDAQ: APRI ) is off 26.7% after hours following word of a public offering of common stock and warrants . More news on: Apricus Biosciences, Inc, Healthcare stocks news, Stocks on the move, Read more … read more...

Apricus Biosciences -27% on offering of stock, warrants

via: SeekingAlpha at 2018-03-27 18:51:07:000

Apricus Biosciences (NASDAQ: APRI ) is off 26.7% after hours following word of a public offering of common stock and warrants . More news on: Apricus Biosciences, Inc, Healthcare stocks news, Stocks on the move, Read more … read more...

Update On February Biotech Catalysts: What Happened And What's Next

via: SeekingAlpha at 2018-03-02 09:10:21:000

On January 31 st , I published an article discussing major catalysts facing three interesting developmental biotech companies: Dynavax Technologies ( DVAX ), Novavax ( NVAX ), and Puma Biotechnology ( PBYI ). I followed that up shortly after with an article on one more biotech with a crucia… read more...

Update On February Biotech Catalysts: What Happened And What's Next

via: SeekingAlpha at 2018-03-02 09:10:21:000

On January 31 st , I published an article discussing major catalysts facing three interesting developmental biotech companies: Dynavax Technologies ( DVAX ), Novavax ( NVAX ), and Puma Biotechnology ( PBYI ). I followed that up shortly after with an article on one more biotech with a crucia… read more...

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-01 19:13:06:000

Apricus Biosciences, Inc. (APRI) Q4 2017 Earnings Conference Call March 1, 2018 4:30 PM ET Executives Matt Beck Vice President-The Trout Group LLC Rich Pascoe Chief Executive Officer, Principal Accounting Officer, Secretary and Director Kelly Deck Execu… read more...

Apricus Biosciences' (APRI) CEO Rich Pascoe on Q4 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2018-03-01 19:13:06:000

Apricus Biosciences, Inc. (APRI) Q4 2017 Earnings Conference Call March 1, 2018 4:30 PM ET Executives Matt Beck Vice President-The Trout Group LLC Rich Pascoe Chief Executive Officer, Principal Accounting Officer, Secretary and Director Kelly Deck Execu… read more...

Apricus Biosciences misses by $0.84

via: SeekingAlpha at 2018-03-01 16:03:33:000

Apricus Biosciences (NASDAQ: APRI ): Q4 EPS of -$0.99 misses by $0.84 . Press Release More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , read more...

Apricus Biosciences misses by $0.84

via: SeekingAlpha at 2018-03-01 16:03:33:000

Apricus Biosciences (NASDAQ: APRI ): Q4 EPS of -$0.99 misses by $0.84 . Press Release More news on: Apricus Biosciences, Inc, Earnings news and commentary, Healthcare stocks news, , read more...

3 Things In Biotech You Should Learn Today: February 19, 2018

via: SeekingAlpha at 2018-02-20 15:20:43:000

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec… read more...

3 Things In Biotech You Should Learn Today: February 19, 2018

via: SeekingAlpha at 2018-02-20 15:20:43:000

Note: Subscribers to Avisol Capital Partners Total Pharma Tracker got an early look at this publication. Welcome to another edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with the fast-moving world of pharmaceutical and biotec… read more...

Midday Gainers / Losers (2/20/2018)

via: SeekingAlpha at 2018-02-20 12:47:14:000

Gainers: FOGO +25% . VYGR +22% . DIN +21% . DCAR +21% . ACHV +19% . DPW +16% . APRI +17% . ECYT +14% . DQ +13% . AVGR +13% . More news on: Fogo de Chao, Voyager Therapeutics, Dine Brands Global, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (2/20/2018)

via: SeekingAlpha at 2018-02-20 12:47:14:000

Gainers: FOGO +25% . VYGR +22% . DIN +21% . DCAR +21% . ACHV +19% . DPW +16% . APRI +17% . ECYT +14% . DQ +13% . AVGR +13% . More news on: Fogo de Chao, Voyager Therapeutics, Dine Brands Global, Inc., Stocks on the move, , Read more … read more...

Midday Gainers / Losers (2/16/2018)

via: SeekingAlpha at 2018-02-16 12:44:12:000

Gainers: XTNT +54% . FTFT +25% . SNCR +22% . GEN +20% . CALA +21% . ATOM +20% . MULE +18% . NVAX +14% . NAVG +14% . CATB +14% . More news on: Xtant Medical Holdings, Inc., Future Fintech Group Inc, Synchronoss Technologies, Inc., Stocks on the move, , R… read more...

Midday Gainers / Losers (2/16/2018)

via: SeekingAlpha at 2018-02-16 12:44:12:000

Gainers: XTNT +54% . FTFT +25% . SNCR +22% . GEN +20% . CALA +21% . ATOM +20% . MULE +18% . NVAX +14% . NAVG +14% . CATB +14% . More news on: Xtant Medical Holdings, Inc., Future Fintech Group Inc, Synchronoss Technologies, Inc., Stocks on the move, , R… read more...

Biotech Forum Daily Digest For February 12th

via: SeekingAlpha at 2018-02-12 10:14:39:000

T here are some days we can claim and there are other days that claim us . Kamand Kojouri Investors got treated like 'rented mules' this week as the markets suffered their worst weekly loss in some two years. Four of the five trading sessions featured over 1,000 point sw… read more...

Biotech Forum Daily Digest For February 12th

via: SeekingAlpha at 2018-02-12 10:14:39:000

T here are some days we can claim and there are other days that claim us . Kamand Kojouri Investors got treated like 'rented mules' this week as the markets suffered their worst weekly loss in some two years. Four of the five trading sessions featured over 1,000 point sw… read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Key events next week - healthcare

via: SeekingAlpha at 2018-02-09 12:34:12:000

Noteworthy events for the week of Feb. 11 - 17 for healthcare investors: More news on: Humanigen, Inc., Can-Fite Biopharma Ltd, Invitae, Healthcare stocks news, Read more … read more...

Another February Biotech Catalyst To Watch

via: SeekingAlpha at 2018-02-07 09:34:07:000

At the end of January, I published the February entry of my monthly biotech catalysts preview. While the three companies discussed, Dynavax Technologies ( DVAX ), Novavax ( NVAX ), and Puma Biotechnology ( PBYI ) all have interesting catalysts ahead of them this month, they are not alone. Ev… read more...

Another February Biotech Catalyst To Watch

via: SeekingAlpha at 2018-02-07 09:34:07:000

At the end of January, I published the February entry of my monthly biotech catalysts preview. While the three companies discussed, Dynavax Technologies ( DVAX ), Novavax ( NVAX ), and Puma Biotechnology ( PBYI ) all have interesting catalysts ahead of them this month, they are not alone. Ev… read more...

Another February Biotech Catalyst To Watch

via: SeekingAlpha at 2018-02-07 09:34:07:000

At the end of January, I published the February entry of my monthly biotech catalysts preview. While the three companies discussed, Dynavax Technologies ( DVAX ), Novavax ( NVAX ), and Puma Biotechnology ( PBYI ) all have interesting catalysts ahead of them this month, they are not alone. Ev… read more...

Midday Gainers / Losers (2/5/2018)

via: SeekingAlpha at 2018-02-05 12:44:32:000

Gainers: AFMD +33% . EYES +20% . CHCI +18% . IPWR +12% . ARMO +13% . ENPH +12% . APRI +11% . NGVC +10% . GRVY +10% . OGEN +9% . More news on: Affimed Therapeutics, Second Sight Medical Products, Comstock Homebuilding Companies, Inc., Stocks on the move, … read more...

Premarket Gainers as of 9:05 am (02/05/2018)

via: SeekingAlpha at 2018-02-05 09:12:29:000

CAPR +15% on accelerated review status in U.S. for Duchenne candidate CAP-1002. More news on: Capricor Therapeutics, Inc., Apricus Biosciences, Inc, Second Sight Medical Products, Stocks on the move, Read more … read more...

Midday Gainers / Losers

via: SeekingAlpha at 2018-01-05 12:40:10:000

Gainers: DELT +224% . CNIT +57% . SKY +42% . YGE +29% . CCIH +26% . ORPN +26% . DWCH +24% . CBMG +17% . APRI +15% . CRSP +14% . More news on: Delta Technology Holdings Limited, China Information Technology, Skyline Corp., Stocks on the move, Read more …. read more...

Apricus Biosciences' (APRI) CEO Richard Pascoe on Q3 2017 Results - Earnings Call Transcript

via: SeekingAlpha at 2017-11-05 05:06:24:000

Apricus Biosciences, Inc. (APRI) Q3 2017 Earnings Conference Call November 02, 2017, 16:30 ET Executives Matthew Beck - VP, The Trout Group LLC Richard Pascoe - CEO, Principal Accounting Officer, Secretary and Director Kelly Deck - Executive Director of Finance Analysts Mit… read more...

Equity offering registration roundup - healthcare

via: SeekingAlpha at 2017-11-03 08:27:51:000

Recent S-3 filings: More news on: Ironwood Pharmaceuticals, Inc., Apricus Biosciences, Inc, Healthcare stocks news, Read more … read more...

Apricus Biosciences (APRI) Presents At 2017 BIO Investor Forum - Slideshow

via: SeekingAlpha at 2017-10-18 14:23:58:000

The following slide deck was published by Apricus Biosciences, Inc in conjunction with this Read more … read more...

Apricus Biosciences (APRI) Presents At Rodman & Renshaw 19th Annual Global Investment Conference - Slideshow

via: SeekingAlpha at 2017-09-12 13:25:37:000

The following slide deck was published by Apricus Biosciences, Inc in conjunction with this Read more … read more...

PDUFA Run-Up Idea: Apricus Biosciences

via: SeekingAlpha at 2017-09-04 05:32:40:000

Shares of Apricus Bisociences ( APRI ) have lost over 90% in the past three years and 50% in the past year alone. However, year-to-date shares have rebounded slightly by around 20%. APRI data by YCharts The stock popped on my radar recently when the company announced that the FDA has a… read more...

Faison's Weekend Review And Scans

via: SeekingAlpha at 2017-09-04 04:59:08:000

Over the past few months quite a few readers have been asking me where and how to scan and find ideas. From busted IPOs to insider buys, technical breakouts to unusual volume, there are plenty of ways to find interesting ideas that would take much longer than this piece can cover. Instead, I c… read more...

3 Things In Biotech You Should Learn Today: September 1, 2017

via: SeekingAlpha at 2017-09-01 08:00:00:000

Welcome to a new edition of "3 Things In Biotech You Should Learn Today," a daily digest dedicated to helping you keep pace with recent findings in the biotech and pharma industries. Let's dive in! Pfizer heads toward first-line CML approval Of all the big competitors in the treatment of… read more...

FDA accepts Apricus Bio's resubmitted Vitaros NDA, action date February 17; shares up 6% premarket

via: SeekingAlpha at 2017-08-31 08:41:02:000

Nano cap Apricus Biosciences (NASDAQ: APRI ) perks up 6% premarket on average volume on the heels of its announcement that the FDA has accepted its resubmitted New Drug Application (NDA) for Vitaros (alprostadil), an on-demand topical cream for the treatment of erectile dysfunc… read more...

Apricus resubmits U.S. marketing application for ED cream Vitaros

via: SeekingAlpha at 2017-08-29 11:18:26:000

Apricus Biosciences ( APRI -0.7% ) has refiled a New Drug Application (NDA) with the FDA seeking approval for Vitaros (alprostadil), an on-demand topical cream for the treatment of erectile dysfunction. If accepted for review, the agency's action date should be sometime in Q1 2018. Mor… read more...

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-10-24 10.0 1.0 10.0
Data provided for free by IEX